Hassan, Mona, et al. “Effect of Pemafibrate, a Selective Peroxisome Proliferator-Activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis”. Translation: The University of Toledo Journal of Medical Sciences, vol. 13, no. S3, June 2025, https://doi.org/10.46570/utjms-2025-1397.